Charles River Laboratories International (CRL) Enterprise Value (2009 - 2025)

Charles River Laboratories International's Enterprise Value history runs 17 years deep, the most recent figure standing at -$208.5 million for Q4 2025.

• In Q4 2025, Enterprise Value fell 35.83% year-over-year to -$208.5 million; the TTM figure through Dec 2025 stood at -$208.5 million (down 35.83% YoY), while the FY2025 annual figure was -$208.5 million, down 35.83% from the prior year.
• Enterprise Value for Q4 2025 stood at -$208.5 million, down from -$202.2 million in the prior quarter.
• The five-year high for Enterprise Value was -$117.2 million in Q3 2023, with the low at -$461.2 million in Q1 2021.
• The 5-year median for Enterprise Value is -$183.0 million (2021), against an average of -$193.0 million.
• The sharpest annual moves came in 2022 and 2024: Enterprise Value jumped 59.66% in 2022, then sank 69.72% in 2024.
• Charles River Laboratories International's Enterprise Value stood at -$188.2 million in 2021, then declined by 1.74% to -$191.5 million in 2022, then slipped by 14.92% to -$220.0 million in 2023, then jumped by 30.25% to -$153.5 million in 2024, then slumped by 35.83% to -$208.5 million in 2025.
• Business Quant data shows CRL's Enterprise Value at -$208.5 million in Q4 2025, -$202.2 million in Q3 2025, and -$142.9 million in Q2 2025.